Diana Lennon
#179,329
Most Influential Person Now
Pediatrician scientist
Diana Lennon's AcademicInfluence.com Rankings
Diana Lennonmedical Degrees
Medical
#3711
World Rank
#4213
Historical Rank
Pediatrics
#106
World Rank
#120
Historical Rank
Diana Lennonphilosophy Degrees
Philosophy
#11821
World Rank
#16340
Historical Rank
Logic
#8632
World Rank
#10825
Historical Rank
Download Badge
Medical Philosophy
Diana Lennon's Degrees
- Doctorate Medicine Stanford University
- PhD Pediatrics University of California, San Francisco
Why Is Diana Lennon Influential?
(Suggest an Edit or Addition)According to Wikipedia, Diana Rosemary Lennon was a New Zealand academic and pediatrician, specialising in infectious diseases, and was a full professor at the University of Auckland. Academic career Lennon graduated with a Bachelor of Medicine, Bachelor of Surgery from the University of Otago in 1972. She was awarded FRACP in Pediatrics in 1978.
Diana Lennon's Published Works
Published Works
- Household crowding a major risk factor for epidemic meningococcal disease in Auckland children (2000) (286)
- MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. (2005) (279)
- New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. (1998) (161)
- A 10‐year serogroup B meningococcal disease epidemic in New Zealand: Descriptive epidemiology, 1991–2000 (2001) (125)
- Delayed immunisation and risk of pertussis in infants: unmatched case-control study (2003) (103)
- Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué (2016) (103)
- Incidence of acute rheumatic fever in New Zealand children and youth (2012) (102)
- School-Based Prevention of Acute Rheumatic Fever: A Group Randomized Trial in New Zealand (2009) (89)
- Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic (2011) (83)
- Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis (2008) (83)
- Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. (2008) (76)
- Meta-Analysis of Trials of Streptococcal Throat Treatment Programs to Prevent Rheumatic Fever (2009) (74)
- Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. (1994) (74)
- Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. (2006) (70)
- Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. (1994) (69)
- Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand (2005) (68)
- Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand (1994) (66)
- Incidence, Risk Factors, and Outcomes of Panton-Valentine Leukocidin-Positive Methicillin-Susceptible Staphylococcus aureus Infections in Auckland, New Zealand (2010) (64)
- From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. (2005) (62)
- Intravenous Immunoglobulin in Acute Rheumatic Fever: A Randomized Controlled Trial (2001) (58)
- New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16–24 Months (2007) (54)
- Rheumatic fever recurrence prevention: A nurse‐led programme of 28‐day penicillin in an area of high endemnicity (2011) (53)
- The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic. (2004) (52)
- Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand (2012) (52)
- The Strategy to Control New Zealand's Epidemic of Group B Meningococcal Disease (2004) (50)
- Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop. (2014) (49)
- Cost‐effectiveness of palivizumab in New Zealand (2002) (49)
- Late antenatal carriage of group B Streptococcus by New Zealand women (2002) (47)
- Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand. (2009) (43)
- Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand (2019) (42)
- Serious suppurative Group A streptococcal infections in previously well children (1988) (42)
- Emerging infectious diseases among indigenous peoples. (2001) (41)
- Overcrowding and infectious diseases--when will we learn the lessons of our past? (2000) (39)
- Rheumatic fever registers in New Zealand (39)
- Longitudinal study of poststreptococcal disease in Auckland; rheumatic fever, glomerulonephritis, epidemiology and M typing 1981-86. (1988) (39)
- Early‐onset neonatal group B streptococcal infections in New Zealand 1998−1999 (2002) (38)
- Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand. (1992) (38)
- Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine (2009) (38)
- Palivizumab prophylaxis of respiratory syncytial virus infection in high‐risk infants (2002) (38)
- An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. (2006) (38)
- Early‐onset neonatal group B streptococcus sepsis following national risk‐based prevention guidelines (2016) (36)
- Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. (2011) (35)
- Increasing Incidence and Sociodemographic Variation in Community-onset Staphylococcus Aureus Skin and Soft Tissue Infections in New Zealand Children (2013) (33)
- Rotavirus hospitalisation in New Zealand children under 3 years of age (2006) (33)
- Prospective population‐based study on the burden of disease from post‐streptococcal glomerulonephritis of hospitalised children in New Zealand: Epidemiology, clinical features and complications (2013) (32)
- A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand (2003) (31)
- Phase II meningococcal B vesicle vaccine trial in New Zealand infants (2008) (30)
- Impact of pneumococcal vaccine on hospital admission with lower respiratory infection in children resident in South Auckland, New Zealand. (2013) (30)
- Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic (2012) (30)
- Trends in hospitalization and mortality from rotavirus disease in New Zealand infants. (1999) (30)
- The primary prevention of rheumatic fever (2010) (30)
- Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens (2007) (30)
- Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002-2012: a national population-based study. (2015) (29)
- Household characteristics of children under 2 years admitted with lower respiratory tract infection in Counties Manukau, South Auckland. (2012) (29)
- An outbreak of meningococcal disease in Auckland, New Zealand. (1989) (29)
- Infective Endocarditis in New Zealand Children 1994–2012 (2014) (29)
- Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland. (1993) (28)
- Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection (2013) (27)
- Meningococcal disease epidemiology and control in New Zealand. (1995) (27)
- The epidemiology of acute rheumatic fever in Northland, 2002-2011. (2013) (27)
- First Presentation Acute Rheumatic Fever is Preventable in a Community Setting: A School-based Intervention (2017) (25)
- Nurse-led school-based clinics for rheumatic fever prevention and skin infection management: evaluation of Mana Kidz programme in Counties Manukau. (2016) (24)
- Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers (2011) (23)
- Nurse-led school-based clinics for skin infections and rheumatic fever prevention: results from a pilot study in South Auckland. (2013) (22)
- Acute rheumatic fever in children: recognition and treatment. (2004) (20)
- Meningococcal disease in Auckland, July 1992 - June 1994. (1999) (20)
- Persistence, Discordance and Diversity of Staphylococcus aureus Nasal and Oropharyngeal Colonization in School-aged Children (2016) (19)
- Haemophilus influenzae type b disease in Auckland children 1981-87. (1989) (19)
- Acute Rheumatic Fever in Children (1955) (19)
- Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand. (2004) (19)
- Acute rheumatic fever in the Waikato District Health Board region of New Zealand: 1998-2004. (2008) (18)
- Guidelines for sore throat management in New Zealand. (2009) (18)
- Randomized controlled trial of steroids in pertussis. (1992) (18)
- The microbiology of chronic otitis media with effusion in a group of Auckland children. (1996) (17)
- Respiratory virus detection during hospitalisation for lower respiratory tract infection in children under 2 years in South Auckland, New Zealand (2017) (17)
- Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration (2006) (17)
- New Zealand Guidelines for Rheumatic Fever. 1: Diagnosis, Management and Secondary Prevention (2006) (16)
- Patients with rheumatic fever recurrences. (1984) (15)
- Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. (2016) (15)
- Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening. (2017) (15)
- Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children (2014) (14)
- Rheumatic heart disease detected by echocardiographic screening. (2007) (13)
- Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013. (2014) (13)
- New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the American Heart Association Jones criteria. (2013) (13)
- Primary Prevention of Rheumatic Fever. (2016) (13)
- Longitudinal study of influenza B symptomatology and interferon production in children and college students (1983) (13)
- An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial. (2013) (13)
- Ribavirin therapy of respiratory syncytial virus infections. (1994) (13)
- Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference? (2017) (12)
- The epidemiology of rheumatic fever in the Tairawhiti/Gisborne region of New Zealand: 1997-2009. (2012) (12)
- Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry. (2016) (12)
- Registered nurse assessment and treatment of skin sepsis in New Zealand schools: the development of protocols. (2013) (12)
- The clinical features of paediatric meningococcal disease Auckland, 1985-87. (1989) (12)
- Comparison of illumigene Group A Streptococcus Assay with Culture of Throat Swabs from Children with Sore Throats in the New Zealand School-Based Rheumatic Fever Prevention Program (2015) (12)
- Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever (1996) (11)
- Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine. (1999) (10)
- High admission rate of infants and young children with whooping cough: clinical aspects and preventive implications (1984) (10)
- Antimicrobial stewardship using pharmacy data for the nurse-led school-based clinics in Counties Manukau District Health Board for management of group A streptococcal pharyngitis and skin infection. (2016) (10)
- Septic Arthritis and Acute Rheumatic Fever in Children: The Diagnostic Value of Serological Inflammatory Markers (2014) (10)
- Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents (2015) (10)
- Kawasaki disease in Auckland, 1979-1988. (1990) (10)
- Retrospective epidemiology of acute rheumatic fever: a 10-year review in the Waikato District Health Board area of New Zealand. (2014) (10)
- Trauma-related hospitalizations among urban adolescents in New Zealand: priorities for prevention. (1999) (9)
- Pertussis control in New Zealand. (1994) (9)
- Monoarthritis in rheumatic fever? (2007) (9)
- Control of pertussis. (1996) (8)
- Prevalence and impact of chronic childhood conditions in Auckland, New Zealand (1996) (8)
- The immunogenicity of Haemophilus influenzae: Meningococcal protein conjugate vaccine in Polynesian and non‐Polynesian New Zealand infants (1997) (7)
- New Zealand Guidelines for Rheumatic Fever. 3: Proposed Rheumatic Fever Primary Prevention Programme (2009) (7)
- Chickenpox immunisation in New Zealand. (1998) (7)
- Severe outbreak of meningococcal disease in Auckland. (1987) (7)
- Re: "a prospective study of the effectiveness of the New Zealand meningococcal B vaccine". (2008) (7)
- Post‐streptococcal glomerulonephritis: Some reduction in a disease of disparities (2018) (6)
- New Zealand Guidelines for Rheumatic Fever. 2: Group A Streptococcal Sore Throat Management (2008) (6)
- Control of epidemic group A meningococcal disease in Auckland. (1993) (6)
- Disappointing performance of rapid antigen detection tests for group A streptococcus in the Auckland school-based sore throat programme. (2014) (6)
- Late antenatal carriage of group B streptococcus (2001) (5)
- Measles epidemic in Auckland 1984-85. (1987) (5)
- The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic. (2008) (5)
- Rubella epidemic. (1990) (5)
- A Clear-cut Case of Acute Rheumatic Fever After Group G Streptococcal Pharyngitis in New Zealand. (2018) (5)
- Epidemiology, management, and prevention of meningococcal infections. (1994) (4)
- CRyptOcoccosis in Newcastle and the hUnTer (CRONUT) - An epidemiological study. (2020) (4)
- Invasive Group A Streptococcal Infection and Vaccine Implications, Auckland, New Zealand (2011) (4)
- In vitro comparison of four rapid antigen tests for group A streptococcus detection. (2014) (4)
- An important investment to control Acute Rheumatic Fever needs to run its course. (2015) (4)
- Is a rheumatic fever register the best surveillance tool to evaluate rheumatic fever control in the Auckland region? (2017) (4)
- Re: Epidemiology of acute rheumatic fever in New Zealand 1996-2005 by Jaine R et al. 2008;44:564. (2009) (3)
- Burden and Cost of Rheumatic Fever and Rheumatic Heart Disease in New Zealand: Focus on School Age Children A Report to the Ministry of Health. (2010) (3)
- Childhood immunisation in New Zealand. (1994) (3)
- Yersinia arthritis versus acute rheumatic fever in a boy. (1992) (3)
- Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. (2018) (3)
- Once-daily amoxicillin for Group A Streptococcal (GAS) sore throat as the other first-line option: a clarification of the NZ sore throat guidelines. (2011) (3)
- Community‐acquired invasive Staphylococcus aureus: Uncovering disparities and the burden of disease in Auckland children (2020) (2)
- Re: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, O'Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Vaccine 2007;25(16):3075-9. (2007) (2)
- A comparison of two pertussis epidemics in Auckland. (1997) (2)
- Antimicrobials in the management of invasive meningococcal disease (2001) (2)
- Control of whooping cough in New Zealand; slow progress. (1995) (2)
- Microbiology of septic arthritis in young Auckland children (2021) (2)
- Communicating information about sore throats and rheumatic fever to South Auckland high-school students. (2000) (2)
- CO-TRIMOXAZOLE TOXICITY (1984) (1)
- Rheumatic fever as an indicator of child health. (2017) (1)
- Economic evaluation of a school clinic intervention to prevent rheumatic fever. (2013) (1)
- Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency (2020) (1)
- No longterm oral polio vaccine virus persistence after its removal from the immunisation schedule in New Zealand (2005) (1)
- Antibiotic susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in South Auckland children (2010) (1)
- Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia. (2007) (1)
- Hepatitis B--prevention of perinatal transmission. (2002) (1)
- Re: Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease, Nokleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P. Vaccine 2007;25(16):3080-4. (2007) (1)
- The Microbiology of Septic Arthritis in Young Auckland Children (2016) (1)
- School-based Streptococcal A Sore-throat Treatment Programs and Acute Rheumatic Fever Amongst Indigenous Māori: A Retrospective Cohort Study (2020) (1)
- The prevention of rheumatic fever. (1967) (1)
- Cryptosporidium infestation in hospitalised urban children. (1985) (1)
- Haemophilus influenzae type b disease: prospects for prevention in New Zealand. (1994) (1)
- OPV virus circulation and evolution investigated in New Zealand (2003) (0)
- Rheumatic heart disease. (1994) (0)
- Tuberculosis in children. (1995) (0)
- The MeCune‐Albright Syndrome (1977) (0)
- Commentary on ‘Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children’ (2011) (0)
- The McCune-Albright syndrome. (1977) (0)
- LibGuides: Health & Wellness: Fitness & Exercise (2020) (0)
- Secondary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease (2021) (0)
- Comment on: Safety review : Two outer membrane vesicle (OMV) vaccines against systemic neisseria meningitidis serogroup B disease, et al., Author's reply (2007) (0)
- Comparing the Old with the New: Randomised controlled trial of three different treatments for mild to moderate impetigo in children – experience of setting up a multicenter study (2017) (0)
- Monoarthritis in rheumatic fever? Author's reply (2007) (0)
- Degree of C3 Depletion as a Prognostic Factor for APSGN in Children in the Kimberley Region of Western Australia (2018) (0)
- The detection of HIV in infants and children. (1992) (0)
- Measles control. (1997) (0)
- Comment on: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, et al., Authors' reply (2007) (0)
- Sequential Intravenous High Dose Oral Antibiotics in the Treatment of Osteoarticular Infections in Children: A Randomized Controlled Trial (2016) (0)
- Childhood immunisation in Rotorua. (1999) (0)
- 2328. Community-Onset Invasive Bacterial Infections in Infants Under 3 Months–10 Years of Experience in Auckland, New Zealand (2018) (0)
- Impact of a diagnostic stewardship initiative of bacterial 16s rRNA sequencing referrals from a regional laboratory (2021) (0)
- Household Characteristics of Children Under Two Years Admitted with Lower Respiratory Infection in South Auckland (2011) (0)
- PO601 New Zealand’s Ongoing Success In Preventing First Attacks of Acute Rheumatic Fever (2018) (0)
- O069 New Zealand’s Unique Experiment: Primary prevention of rheumatic fever with a focus on schools (2014) (0)
- Penicillin- and cephalosporin-resistant pneumococcal meningitis: the future is now. The Infection and Immunisation Committee, New Zealand Paediatric Society. (1999) (0)
- Early onset group B streptococcal infection in New Zealand (2001) (0)
- How Should Sore Throats Be Managed? Performance of Four Group A Streptococcal Sore Throat Prediction Rules in New Zealand Children (2015) (0)
- Detection of dengue virus NS1 provides early diagnosis and is a prognostic marker of disease progression (2003) (0)
- Impact of PCV7 on antibiotic susceptibiity of nasophayngeal Streptococcus pneumoniae in South Auckland children (2011) (0)
- Impact of conjugate pneumococcal vaccine on nasopharyngeal S.pneumoniae serotypes and antibiotic susceptibility over 7 years (2015) (0)
- Borrowing a Bird's Eye: Teaching Urban-Based Environmental Science with Humanities and Archival Resources (2018) (0)
- The epidemiology and acute costs of paediatric pneumococcal infection in New Zealand (2003) (0)
- LibGuides: Health & Wellness: Library Health & Wellness Programs (2020) (0)
- A Randomized, Placebo-Controlled Trial of Intravenous Immune Globulin (IVIG) in the Treatment of Acute Rheumatic Fever (ARF). † 148 (1997) (0)
- PIN26: LIFETIME GOVERNMENTAL COSTS OF SEVERE SEQUELAE OF PNEUMOCOCCAL MENINGITIS IN A WELFARE STATE (2003) (0)
- Late antenatal carriage of group B streptococcus (GBS) (2001) (0)
- PT290 Long-Term Outcomes of New Zealand Children and Young Adults Undergoing Surgery for Rheumatic Heart Disease (2016) (0)
- Rotavirus gastroenteritis: is vaccine prevention near at hand? (1997) (0)
- THE NEW ZEALAND MEDICAL JOURNAL (2002) (0)
- Early onset group B streptococcal (EOGBS) neonatal infection in New Zealand (NZ) (2001) (0)
- PM288 Adherence to Secondary Prophylaxis for Patients Diagnosed With Rheumatic Heart Disease by Echocardiographic Screening (2016) (0)
- Letter to the Editor (2009) (0)
- Pneumococcal Vaccine Decreases Hospitalised Community-Acquired Pneumonia in Children (2011) (0)
This paper list is powered by the following services:
Other Resources About Diana Lennon
What Schools Are Affiliated With Diana Lennon?
Diana Lennon is affiliated with the following schools: